- Home
- LAB vs CLDT Comparison
LAB vs CLDT Comparison
Compare LAB & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAB
- CLDT
- Stock Information
- Founded
- LAB 1999
- CLDT 2009
- Country
- LAB United States
- CLDT United States
- Employees
- LAB N/A
- CLDT N/A
- Industry
- LAB Biotechnology: Laboratory Analytical Instruments
- CLDT Real Estate Investment Trusts
- Sector
- LAB Industrials
- CLDT Real Estate
- Exchange
- LAB Nasdaq
- CLDT Nasdaq
- Market Cap
- LAB 372.1M
- CLDT 351.7M
- IPO Year
- LAB 2011
- CLDT 2010
- Fundamental
- Price
- LAB $1.34
- CLDT $7.33
- Analyst Decision
- LAB Buy
- CLDT Strong Buy
- Analyst Count
- LAB 2
- CLDT 2
- Target Price
- LAB $2.50
- CLDT $10.75
- AVG Volume (30 Days)
- LAB 2.8M
- CLDT 259.1K
- Earning Date
- LAB 07-30-2025
- CLDT 08-06-2025
- Dividend Yield
- LAB N/A
- CLDT 4.86%
- EPS Growth
- LAB N/A
- CLDT N/A
- EPS
- LAB N/A
- CLDT 0.06
- Revenue
- LAB $169,687,000.00
- CLDT $316,297,000.00
- Revenue This Year
- LAB N/A
- CLDT N/A
- Revenue Next Year
- LAB $12.18
- CLDT $1.12
- P/E Ratio
- LAB N/A
- CLDT $127.78
- Revenue Growth
- LAB 33.86
- CLDT 1.79
- 52 Week Low
- LAB $0.92
- CLDT $5.83
- 52 Week High
- LAB $2.41
- CLDT $10.00
- Technical
- Relative Strength Index (RSI)
- LAB 58.76
- CLDT 56.29
- Support Level
- LAB $1.27
- CLDT $7.05
- Resistance Level
- LAB $1.41
- CLDT $7.46
- Average True Range (ATR)
- LAB 0.11
- CLDT 0.18
- MACD
- LAB 0.01
- CLDT 0.02
- Stochastic Oscillator
- LAB 50.00
- CLDT 78.69
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.
About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.